Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
C. O'Donnell (Pittsburgh, United States of America). The development of insulin resistance in a murine model of intermittent hypoxia. Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

Member's Comments

No comment yet.

Related content which might interest you: A potential role for insulin resistance in experimental pulmonary hypertension Source: Eur Respir J 2013; 41: 861-871 Year: 2013 Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019 The effects and mechanisms of chronic intermittent hypoxia on insulin resistance and glucose tolerance in non-obese rats Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 Peripheral insulin resistance accounts for impaired glucose tolerance and is associated with systemic inflammation in COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Effect of chronic intermittent hypoxia on respiratory function of mitochondrion in genioglossus cells of rat and intervention role of adiponectin Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools Year: 2010 Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4)  1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017 Intermittent hypoxia induces lung growth in adult mice Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2011; 39: 215-217 Year: 2012 Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea Source: Eur Respir J 2012; 39: 215-217 Year: 2012 MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 A unique session of aerobic exercise does not decrease pulmonary inflammation in a murine mice model of asthma Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 Time course of insulin antibody response during inhaled insulin therapy does not correlate with changes in pulmonary function Source: Eur Respir J 2005; 26: Suppl. 49, 375s Year: 2005 Direct effects of intermittent hypoxia on pancreatic beta cell function and proliferation Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools Year: 2010 The effect of chronic intermittent hypoxia on hepatic injury and mechanism in lean mice and mice with diet-induced obesity Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014 Bystander tolerance in experimental asthma: a mouse model Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Type 2 diabetes-related “pulmonary insulin resistance” as a novel mechanism that complicates COPD phenotypes in mice Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Evaluation of association between COPD and metabolic syndrome, and insulin resistance Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Acute effects of an aerobic exercise session on airway inflammation in a murine asthma model Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 The role of intermittent nocturnal hypoxia in systemic vascular diseases Source: Lung Science Conference 2006 - Hypoxia in Lung Biology and Disease Year: 2006 Systemic inflammation is enhanced by acute hyperglycaemia and suppressed by insulin in COPD Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011